Patricia van Dijck
Public Communications Contact en GSK Belux .
Perfil
Patricia van Dijck is currently the Director-Market Access & Public Affairs at GSK Belux since 2018.
Prior to this, she worked as an Independent Director at Mithra Pharmaceuticals SA from 2021 to 2023, as a Medical Director at Lundbeck SA from 1998 to 2007, and as the Head-Market Access & Public Affairs at Novartis Belux.
She holds a doctorate degree from the Université Catholique de Louvain.
Cargos activos de Patricia van Dijck
| Empresas | Cargo | Inicio |
|---|---|---|
| GSK Belux | Public Communications Contact | 01/01/2018 |
Antiguos cargos conocidos de Patricia van Dijck.
| Empresas | Cargo | Fin |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Chairman | 01/06/2021 |
| Novartis Belux | Public Communications Contact | - |
Lundbeck SA
 Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Chief Executive Officer | - |
Formación de Patricia van Dijck.
| Université Catholique de Louvain | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The private company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Health Technology |
| Novartis Belux | |
| GSK Belux |
- Bolsa de valores
- Insiders
- Patricia van Dijck
